Do we really need a new monoclonal antibody for Covid-19? Elizabeth Tracey reports
Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
Another monoclonal antibody against Covid-19 has been developed and appears to work in reducing severe disease and hospitalization. This one is unique, however, according to Brian Garibaldi, a critical care medicine expert at Johns Hopkins. Garibaldi: The interesting thing about …
Do we really need a new monoclonal antibody for Covid-19? Elizabeth Tracey reports Read more »
If you’ve been exposed to Covid-19, should you have monoclonal antibody treatment? Elizabeth Tracey reports
Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
Monoclonal antibodies remain a treatment option for those in early stages of Covid infection, even in the face of new oral medications that likely will be available soon. Brian Garibaldi, a critical care medicine expert at Johns Hopkins, says the …
Two new oral medicines for Covid-19 are poised for widespread use, Elizabeth Tracey reports
Podcast: Download (Duration: 1:07 — 1.6MB)
Subscribe: RSS
Both Pfizer and Merck have recently revealed promising data on oral medicines for early Covid-19 infection, with both companies on the threshold of widespread use of the drugs. Brian Garibaldi, a critical care medicine expert at Johns Hopkins, says he …
What do we know about the new oral medicine from Pfizer for Covid? Elizabeth Tracey reports
Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
Pfizer has asked the FDA to approve its new oral medication for Covid-19, called Paxlovid, for people in the early stages of infection. Brian Garibaldi, a critical care medicine expert at Johns Hopkins, reviews the data. Garibaldi: From symptom onset …
What are the recommendations regarding the best insulin to manage diabetes? Elizabeth Tracey reports
Podcast: Download (Duration: 1:06 — 1.5MB)
Subscribe: RSS
More expensive analog insulins are used by the majority of people with diabetes who use insulin, a study by Rita Kalyani, a diabetes expert at Johns Hopkins, and colleagues has shown. Is this practice based in any professional society recommendations? …
What happened to close management of diabetes requiring insulin during the pandemic? Elizabeth Tracey reports
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
When someone is taking insulin for diabetes, it’s important to monitor and manage its use, but during the pandemic, that didn’t happen. That’s according to research by Rita Kalyani, a diabetes expert at Johns Hopkins, and colleagues. Kalyani: We saw …